MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 141 filers reported holding MACROGENICS INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,872 | -0.5% | 402 | +14.2% | 0.00% | – |
| Q2 2023 | $1,882 | -99.4% | 352 | -99.2% | 0.00% | -100.0% |
| Q1 2023 | $321,057 | -51.4% | 44,778 | -54.6% | 0.00% | 0.0% |
| Q4 2022 | $661,000 | +32950.0% | 98,646 | +18442.5% | 0.00% | – |
| Q3 2022 | $2,000 | 0.0% | 532 | +33.0% | 0.00% | – |
| Q2 2022 | $2,000 | -66.7% | 400 | -48.7% | 0.00% | – |
| Q1 2022 | $6,000 | -66.7% | 780 | -33.3% | 0.00% | – |
| Q4 2021 | $18,000 | -50.0% | 1,169 | -33.4% | 0.00% | – |
| Q3 2021 | $36,000 | -53.8% | 1,755 | -38.8% | 0.00% | – |
| Q2 2021 | $78,000 | -13.3% | 2,867 | +1.4% | 0.00% | – |
| Q1 2021 | $90,000 | +190.3% | 2,827 | +107.6% | 0.00% | – |
| Q4 2020 | $31,000 | +121.4% | 1,362 | +145.8% | 0.00% | – |
| Q3 2020 | $14,000 | -12.5% | 554 | 0.0% | 0.00% | – |
| Q2 2020 | $16,000 | -27.3% | 554 | -85.8% | 0.00% | – |
| Q1 2020 | $22,000 | – | 3,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,115,000 | $37,034,000 | 8.81% |
| INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $18,811,000 | 4.45% |
| DAFNA Capital Management LLC | 119,200 | $2,087,000 | 1.49% |
| BB BIOTECH AG | 2,350,112 | $41,150,000 | 1.26% |
| TIGER MANAGEMENT L.L.C. | 239,667 | $4,197,000 | 0.82% |
| Hood River Capital Management LLC | 576,193 | $10,089,000 | 0.70% |
| Bellevue Group AG | 316,418 | $5,540,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 175,000 | $3,064,000 | 0.44% |
| First Light Asset Management, LLC | 61,538 | $1,078,000 | 0.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 54,000 | $945,000 | 0.36% |